Investment
Features
FeesSafety
Academy
More
Pluang+

The Ritz-Carlton Naples, Tiburón unveils a multi-million-dollar resort redesign with new dining and event spaces.

Others
05 Oct 2026
PRNewsWire
View Source
Neutral
The Ritz-Carlton Naples, Tiburón unveils a multi-million-dollar resort redesign with new dining and event spaces.

The Ritz-Carlton Naples, Tiburón has completed a multi-million-dollar transformation featuring refreshed accommodations, a redesigned lobby, an elevated Club Lounge, and new culinary venues including Palmera, Fenrose, and Café Fenrose. The redesign emphasizes natural light, local craftsmanship, and Florida coastal cuisine with a focus on sustainability and local ingredients. The resort also introduced a new event space, Swaying Palm, enhancing its appeal for celebrations and gatherings. This upgrade positions the resort as a premier destination blending luxury, nature, and community engagement in Naples, Florida.

The Ritz-Carlton Naples, Tiburón's transformation is noted alongside a Consumer Cyclical sector breadth of 68 stocks rising and 44 falling out of 112 priced on Pluang. For readers following this sector, here is Pluang's market snapshot as of Oct 06, 2026 03:42 WIB: DKNG (DraftKings Inc) rose 5.51% to USD 19.61 with a typical hold time of 55 days and 88% buy order activity, RSI (Rush Street Interactive Inc) increased 5.35% to USD 21.08 with a typical hold time of 13 days, and W (Wayfair Inc) gained 4.84% to USD 106.15 with a typical hold time of 8 days.

More News

Applied Digital eyes $1B net income by 2027 amid AI data center expansion, Q1 loss expected.

Applied Digital eyes $1B net income by 2027 amid AI data center expansion, Q1 loss expected.

Applied Digital is set to report a fiscal Q1 loss of $0.30 per share on $116.3 million revenue, reflecting ongoing investments in AI and high-performance data centers. The company has expanded its Polaris Forge 1 campus to 250 MW operational capacity...

Company Fundamentals
Bullish
1 hour ago
Needham raises Vaxcyte price target after strong Phase 3 trial of VAX-31 vaccine

Needham raises Vaxcyte price target after strong Phase 3 trial of VAX-31 vaccine

Investment firm Needham increased its price target for Vaxcyte to $122 from $110 following positive Phase 3 trial results for Vaxcyte's VAX-31 pneumococcal vaccine. The vaccine met all primary endpoints in the OPUS-1 trial, showing noninferiority to ...

Analyst Insights
Bullish
2 hours ago
GMAB's Rina-S shows 45.9% response in ovarian cancer trial, advancing to Phase 3 studies.

GMAB's Rina-S shows 45.9% response in ovarian cancer trial, advancing to Phase 3 studies.

GMAB's investigational drug Rina-S demonstrated a 45.9% confirmed response rate in a Phase 1/2 trial for platinum-resistant ovarian cancer, with a median response duration of 12.1 months and median progression-free survival of 9.5 months. Despite ser...

Market News
Bullish
3 hours ago
Bitcoin eyes $90K-$93K as Fed rate hike odds drop and ETF inflows support price, but $87.4K resistance remains key.

Bitcoin eyes $90K-$93K as Fed rate hike odds drop and ETF inflows support price, but $87.4K resistance remains key.

Bitcoin's potential rise to $90,000-$93,000 depends on easing Treasury yields and inflation data supporting weaker employment, following a drop in October Fed rate hike odds from 64% to 23%. Despite $2.65 billion in U.S. spot Bitcoin ETF inflows in S...

Analyst Insights
Bullish
4 hours ago
US Treasury drops two crypto surveillance rules, marking a win for privacy but keeping existing exchange checks.

US Treasury drops two crypto surveillance rules, marking a win for privacy but keeping existing exchange checks.

The US Treasury's Financial Crimes Enforcement Network (FinCEN) withdrew two proposed rules that would have required banks and exchanges to report users involved in crypto mixing and self-custody wallet transactions. This move is seen as a significan...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App